Predictive factors of survival time of breast cancer in Kurdistan province of Iran between 2006-2014: A cox regression approach

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 19, 2014, Pages 8483-8488

  Karimi, Asrin ^a   Delpisheh, Ali ^a   Sayehmiri, Kourosh ^b   Saboori, Hojjatollah ^c   Rahimi, Ezzatollah ^c  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Prevention of Psychosocial Injuries   (Iran)

^c KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Iran; Prognostic factors; Survival

Indexed keywords

ADULT; AGED; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; IRAN; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; TIME; YOUNG ADULT;

ADULT; AGED; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84921759796     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.19.8483     Document Type: Article

References (35)

1. American joint committee on cancer AJCC Cancer staging mannual (2002). 3 Ed, New York-Berlin: Springer-Verlag.
2. Akbari M, Mirzaei H, Souri H (2007). 5-year survival of breast cancer in shoada-e-tajrish and jorjani hospitals. Hakim Res J, 9, 39-44.
3. Akhsan A, Aryandono T (2010). Prognostic factors of locally advanced breast cancer patients receiving neoadjuvant and adjuvant chemotherapy. Asian Pac J Cancer, 11, 759-61.
4. Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd. Asian Pac J Cancer Prev, 15, 3571-4.
5. Branicadi F, Chales A, Dana K, Biliary R, Schwartz S (2005). Principle of surgery. 8th ed. New York: McGraw-Hill, Medical Publishing Division.
6. Berrino F, Angelis RD, Sant M, et al (2007). Survival for eight major cancers combined for European adults diagnosed in 1995-99: results of th FUROCARE-4 study. Lancet Oncol, 8, 773-83.
7. Dawood S, Broglio K, Esteva FJ, et al (2008). Deffinig prognosis for women with Breast cancer and CNS metastasis by HER-2 status. Ann Ancol, 19, 1272-48.
8. Ederer F, Axtell LM, Cutler SJ (1961). The relative survival rate: A statistical methodology. Natl cancer Inst Monogr, 6, 101-21.
9. Esteve J, Benhamou E, Croasdale M, Raymond L (1990). Relative survival and the estimation of net survival: Element for further discussion. Stat Med, 9, 529-38.
10. Hosmer DW, Lemeshow S (1999). Applied Survival Analysis: Regression Modeling of Time to Event Data, New York John Wiley & Sons.
11. Horita K, Yamagoush A, Hirose K, et al (2001). Pronostic Factor affecting disease free Survival rate following surgical resection of primary Breast cancer. Eur J Histochem, 45, 73-84.
12. International Agency for Research on Cancer (2006). Cancer Mondial [on line database]. Available from: URL: http//WWW-dep.iarc.fr/Accessed Dec 7.
13. Klein JP, Moeschberger ML (1997). Survival analysis techniques for censored and truncated data, New York: Springer-Verlag.
14. Korizumi M, Yoshimoto M, Kasumi F, Iwase T (2010). An open cohort study of bone metastasis incidence following surgery in breast cancer patients. BMC Cancer, 10, 381-85.
15. Khodabakhshi R, Gohari M, Moghadami Fard Z, Foadzi H, Vahabi N (2011a). Disease-Free survival breast cancer patients and identitification of related factors. Razi J Med Sci, 18, 27-32.
16. Khodabakhshi R, Gohari MR, Moghadami Fard Z, Foadzi H, Vahabi N (2011b). Disease-free survival of breast cancer patients and identification of related factors. Razi journal of Medical Sciences, 18, 27-32.
17. Kaviani A, Neishaboury MR, Mohammadzadeh N, et al (2013). Effects of obesity on presentation of breast cancer, lymph node metastasis and patients survival: A retrospective review. Asian Pac J Cancer Prev, 14, 2225-9.
18. Moran JL, Bersten AD, Solomon PJ, Edibam C, Hunt T (2008a). Modelling survival in acute severe illness: Cox versus accelerated failure time model. J Eval Clin Pract, 14, 83-93.
19. Moradi Marjaneh M, Homaei F, Shamsiyan A, et al (2008b). Relationship between HER-2, P53, Estrogen receptor, progestron receptor and survival rate in Iranian women with breast cancer, 1, 7-17.
20. Mohagheghi MA, Mosavi-Jarrahi A, Malekzade R, et al (2009). Cancer incidence in tehran metropolis: the first report from the tehran population-based cancer rigestery 1998-2001. Arch Iran Med, 12, 15-23.
21. Nicholas EM, Patchell RA, Regine WF, Kwok Y (1766). Palliation of brain and spinal cord metastases. in perez and bradys principles and practice of radiation oncology, USA, 6th. Edition page.
22. Nor Aini A, Wan R, Nor Asia M, et al (2013a). Survival rate of breast cancer patients in Malasiya: a population-based Study. Asian Pac J Cancer Prev, 14, 4591-4.
23. Najafi B, Anvari S, Atrkar Roshan Z (2013). Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev, 14, 5811-6.
24. Orbe J, Ferriera E, Nunez-Anton V (2002). Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med, 21, 3493-510.
25. Rayter Z, Gazet JC, Ford HT, Easton DF, Commbes RC (1990). The Comparison of conservative surgery and radiotherapy with mastectomy in the treatment of early breast cancer. Eur J Surg Oncal, 16, 486-92.
26. Rafiquhhah Khan HM, Saxena A, Gabbidon K, et al (2014a). Survival analysis for white non-hispanic female breast cancer patients. Asian Pac J Cancer Prev, 15, 4049-54.
27. Rafiqhullah Khan HM, Saxena A, Gabbidon K, Rana S, Uddin Ahmed N (2014). Model-based survival estimates of female breast cancer data. Asian Pac J Cancer Prev, 15, 2893-900.
28. Sayehmiri K, Alimoghaddam K, Ghavamzadeh A (2010). Comparision of prognostic factors and death hazard function of acute myeloid leukemia and acute lymphoblastic leukemia patients after bone marrow transplanation. Int J Hematol Oncol Stem Cell Res, 4, 19-28.
29. Saha A, Ghosh SK, Roy C, et al (2013). Demographic and Clinical profile of patients with brain metastases: A retrospective study. Asian J Neurosurg, 8, 151-61.
30. Tsangaris TN, Knox SM, Cheek JH (1992). Tumor Hormon receptor statue and recurrences in premenopausal patients with node-negative Breast carcinoma. Cancer, 69, 984-7.
31. Tewsend M, Neauchamp R, Daniel SB, Matto X, Kenneth L (2004). Sabiton text book of surgery. 17th ed. Amesterdam; Elsevier.
32. Tripsianis G, Papadopoulou E, Romanidis K, et al (2013). Overall survival and clinicopathological characteristics of patients with breast cancer in relation to the expression pattern of HER-2, IL-6, TNF-a and TGF-β1. Asian Pac J Cancer Prev, 14, 6813-20.
33. Thakur S, Singla A, Chen J, et al (2014). Reduced ING1 levels in breast cancer promotes metastasis. Oncotarget, 1-13.
34. Wolberg WH, Street WN, Mngasarian OL (1999). Importance of nuclear morphology in breast cancer prognosis. Clin Cancer Res, 5, 3542-48.
35. Wei XQ, Li X, Xin XJ, Tong ZS, Zhang Sh (2013). Clinical features and survival analysis of very young (age<35) breast cancer patients. Asian Pac J Cancer Prev, 14, 5949, 52.